Skip to content
Screener

Bruker BRKR Q2 2026 earnings

Reported August 4, 2026 · Before market open

Revenue$838.5MMiss by $15.1M
EPS$0.49Beat by $0.11
Revenue estimate$853.6M
EPS estimate$0.38
“We returned to organic revenue growth in the second quarter and our Scientific Instruments segment achieved 10% organic bookings growth year-over-year. Our focus on cost and profitability resulted in solid margin expansion and non-GAAP EPS growth in the quarter. In particular, we achieved strong order bookings growth for our differentiated products and solutions in the semiconductor tools, energy research and biopharma markets. In our academic and medical research business, US academic demand remained soft in Q2, while aca/gov bookings in Europe and China were up strongly. We are gaining confidence in a gradual market recovery, and we anticipate significant organic margin expansion and non-GAAP EPS growth not only this year, but in 2027 as well.”
Frank H. Laukien

Next report

Nov 2, 2026 (in 2 months)
Revenue estimate$867.4M
EPS estimate$0.42

Financials

Q2 2026

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$8.69B+70.6%
Enterprise value$10.33B+38.9%
P/S2.5×+1.0×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Segments

By segment

See full
Bsi Calid$310.3M+8.6%
Bsi Nano$261.3M+3.6%
Bsi Biospin$195.7M+0.2%
Energy And Supercon Technologies$74.2M+11.9%

By geography

See full
Europe Excluding Germany$244.3M+14.5%
Asia Pacific Excluding China$112.4M-11.8%
Other Country$64.3M+7.3%

FAQ

When did Bruker report Q2 2026 earnings?
Bruker (BRKR) reported Q2 2026 earnings on August 4, 2026 before market open.
What were Bruker's Q2 2026 revenue and EPS?
Bruker reported revenue of $838.5M and eps of $0.49 for Q2 2026.
Did Bruker beat estimates in Q2 2026?
Revenue missed the consensus estimate of $853.6M by $15.1M. EPS beat the consensus estimate of $0.38 by $0.11.
How did Bruker's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 5.2% from $797.4M a year earlier and eps grew 53.1% from $0.32.
Where can I find Bruker's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-331511) and the 10-Q periodic report (0001193125-26-335226) directly on SEC EDGAR. The filing index links above go to sec.gov.